<DOC>
	<DOCNO>NCT02802982</DOCNO>
	<brief_summary>Parents infant thrombocytopenic 3-4 day approach consent enter study . For purpose study , thrombocytopenia define platelet count &lt; 60,000/uL platelet count &lt; 100,000/uL prompted platelet transfusion . Following enrollment , platelet count follow infant . Participants enter study day 5 later onset thrombocytopenia ( define ) infant either platelet count &lt; 60,000/uL platelet count &lt; 100,000/uL platelet transfusion order .</brief_summary>
	<brief_title>Mathematical Modeling Predict Duration Thrombocytopenia Neonates</brief_title>
	<detailed_description>Parents infant thrombocytopenic 3-4 day approach consent enter study . For purpose study , thrombocytopenia define platelet count &lt; 60,000/uL platelet count &lt; 100,000/uL prompted platelet transfusion . Following enrollment , platelet count follow infant . Participants enter study , day 5 later onset thrombocytopenia ( define ) , infants either platelet count &lt; 60,000/uL platelet count &lt; 100,000/uL platelet transfusion order . If criterion meet , eligible infant single blood sample drawn ( approx . 800 mcL total ) complete blood count Immature Platelet Fraction ( IPF ) determination panel factor important regulation thrombopoiesis ( include TPO , IL-6 , IL-11 , IL-3 , PF-4 , VEGF , HGF , PDGF , Epo ) . Importantly , patient transfuse platelet count &lt; 100,000/uL , sample need obtain immediately prior platelet transfusion . If patient platelet count &lt; 60,000/uL transfuse , blood obtain time . Following initial sample , platelet count IPF obtain time CBC order clinical indication , use left-over blood store clinical laboratory &lt; 24 hr ( 100 mcL need ) . In addition , left-over blood clinically indicated study collect clinical laboratory , process store -80C future cytokine study . Samples continue collect serial platelet count IPF follow resolution thrombocytopenia , define platelet count &gt; 60,000/uL five day without platelet transfusion . In addition , research nurse collect record infant ' demographic data ( include gestational age , day life , birth weight ) , diagnose , clinical condition time study entry ( respiratory and/or hemodynamic support ) , time volume platelet transfusion , coagulation test , liver enzymes , test kidney function . Moderate severe bleeding also record , use criterion define priori .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Thrombocytopenia , Neonatal Alloimmune</mesh_term>
	<criteria>1 . Are admit one participate NICUs CICU BCH ; 2 . Have postconceptional age ( gestational age + age week ) 23 48 week ; 3 . Have thrombocytopenia , define platelet count &lt; 60,000/uL platelet count &lt; 100,000/uL receive platelet transfusion , â‰¥ 5 day . 1 . Are ECMO ; 2 . Are expect survive attend neonatologist .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Thrombocytopenia</keyword>
	<keyword>Neonates</keyword>
</DOC>